Drug intelligence / Profile preview

KIO017-1

Development stage: Unknown
Administration: Injectable

Overview

KIO017-1 is an injectable, resorbable facial tissue filler developed for aesthetic purposes, specifically for facial volumization and filling in adults seeking improvement in facial appearance. Its mechanism is based on physical filling and volumization of subdermal tissue. The exact molecular composition and detailed mechanism of action are not publicly specified, but it is categorized as a resorbable (biodegradable) soft tissue implant for cosmetic use. The product is undergoing clinical assessment with the primary focus on evaluating its safety and efficacy in healthy adults for facial aesthetic indications[1][8].

Other names: KIO017-1KIO-017-1KIO 017-1KIO017KIO-017KIO 017

Beyond the preview

Go deeper on KIO017-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KIO017-1.

Explore the full profile